HTA Database - Search Results

Sort by Relevance

Search Results [884 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	NIHR Health Technology Assessment programme	Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening
2015	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Economic evaluation of different strategies for screening for Chagas' disease in Spain]
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an evidence-based analysis
2015	Health Quality Ontario (HQO)	Harms of Prostate-Specific Antigen (PSA) screening in prostate cancer: a rapid review
2015	Health Quality Ontario (HQO)	Prostate-Specific Antigen (PSA)–based population screening for prostate cancer: an economic analysis
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for asymptomatic bacteriuria within the framework of the German maternity guidelines, under special consideration of test methods]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Newborn screening for critical congenital heart disease using pulse oximetry]
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part III: carnitine uptake deficiency (CUD); short-chain acyl-CoA dehydrogenase deficiency (SCADD); very long-chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Invitation and fact sheet for breast cancer Screening - Rapid report]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ultrasound screening for abdominal aortic aneurysms]
2015	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Screening for visual impairment in children younger than 6 years - rapid report]
2015	Belgian Health Care Knowledge Centre (KCE)	Cardiovascular pre-participation screening in young athletes
2015	NIHR Health Technology Assessment programme	Screening for psychological and mental health difficulties in young people who offend: a systematic review and decision model
2015	NIHR Health Services and Delivery Research programme	Translation into British Sign Language and validation of the Strengths and Difficulties Questionnaire
2015	Canary Health Service	[Cost-effectiveness of neonatal screening for 3-hydroxy-3-methylglutaric aciduria (HMG)]
2015	Belgian Health Care Knowledge Centre (KCE)	What are the recommended clinical assessment and screening tests during pregnancy?
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Fitness to drive requirements: some recommendations
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vancomycin-resistant enterococci isolation and screening strategies: clinical evidence and cost-effectiveness
2014	Adelaide Health Technology Assessment (AHTA)	Bone mineral density analyses using dual energy x-ray absorptiometry (DXA) for women in their 50th year
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism. Part II: Methylmalonic acidemia, Propionic acidemia, Tyrosinemia type I]
2014	HAYES, Inc.	Cologuard
2014	HAYES, Inc.	Screening for Lynch syndrome
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Diagnosis of gestational diabetes mellitus: evaluation of the new IADPSG criteria]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SoftVue™ system for diagnostic breast imaging
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	HPV OncoTect E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Neonatal screening for lysosomal storage disorders
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for asymptomatic carotid artery stenosis: a systematic review and meta-analysis for the U.S. Preventive Services Task Force
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for vitamin D deficiency: systematic review for the U.S. Preventive Services Task Force Recommendation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Routine ordering of primary pathology examinations in Canada
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for high blood pressure in adults: a systematic evidence review for the U.S. Preventive Services Task Force
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mass thermography screening for infection and prevention: a review of the clinical effectiveness
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[The mortality rate and medical costs identified by a national health examination analysis]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in South Korea]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Infection prevention and control procedures for carbapenemase-producing Enterobacteriaceae: clinical effectiveness and guidelines
2014	NIHR Horizon Scanning Centre (NIHR HSC)	BreathLink™ for breast cancer screening
2014	Belgian Health Care Knowledge Centre (KCE)	A decision aid for an informed choice when patient asks for PSA screening
2014	Medical Services Advisory Committee (MSAC)	National Cervical Screening Program renewal
2014	Belgian Health Care Knowledge Centre (KCE)	Informed choice on breast cancer screening: messages to support informed decision
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening for biotinidase deficiency]
2014	Agencia de Evaluacion de Tecnologias Sanitarias (AETS)	[Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for gonorrhea and chlamydia: systematic review to update the U.S. Preventive Services Task Force Recommendations
2014	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Benefit assessment of an HPV test in primary screening for cervical cancer - Rapid report]
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Cologuard® for colorectal cancer screening
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Pediatric Vision Scanner for the detection of eye conditions in children
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014	Blue Cross Blue Shield Association (BCBS)	Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014	Blue Cross Blue Shield Association (BCBS)	Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer
2014	NIHR Health Technology Assessment programme	A modelled analysis using data from the ARTISTIC trial of the potential effectiveness and cost-effectiveness of HPV testing in cervical cancer screening
2014	Health Council of the Netherlands Gezondheidsraad (GR)	Population screening for breast cancer: expectations and developments
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening for classic galactosemia. Systematic review]
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for congenital adrenal hyperplasia. Systematic Review]
2014	HAYES, Inc.	Magnetic resonance imaging (MRI) for surveillance for breast cancer recurrence following mastectomy and breast reconstruction
2014	Adelaide Health Technology Assessment (AHTA)	Molecular testing for prostate cancer prognosis
2014	Agency for Healthcare Research and Quality (AHRQ)	Primary care screening for abdominal aortic aneurysm: a systematic evidence review for the U.S. preventive services task force
2014	HAYES, Inc.	Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening
2014	HAYES, Inc.	Digital breast tomosynthesis for breast cancer diagnosis and screening
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for very long chain acyl-CoA dehydrogenase deficiency (VLCADD)]
2014	Canary Health Service	[Cost-effectiveness of neonatal screening for primary carnitine deficiency]
2014	HAYES, Inc.	High-resolution anoscopy for the evaluation of anal lesions
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Population-based colorectal cancer screening: guidelines
2013	Canary Health Service	[Cost-effectiveness of newborn screening for sickle cell anemia]
2013	NIHR Health Technology Assessment programme	Systematic review and meta-analysis of the growth and rupture rates of small abdominal aortic aneurysms: implications for surveillance intervals and their cost-effectiveness
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Newborn screening for cystic fibrosis. Efficacy/ effectiveness and implementation protocols]
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening of sickle cell anemia]
2013	NIHR Health Technology Assessment programme	Screening for type 2 diabetes: a short report for the National Screening Committee
2013	Health Quality Ontario (HQO)	Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2013	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Assessment of the benefit of screening in persons under 55 years of age with a family history of colorectal cancer]
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[P16/Ki-67 dual stain in the triage of PAPIII/IIID cytology in cervical cancer screening]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tuberculosis testing for correctional staff: diagnostic accuracy and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prostate cancer screening: a review of the guidelines
2013	HAYES, Inc.	Photoscreening for the detection of amblyopia risk factors in children
2013	NIHR Health Technology Assessment programme	AESOPS: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of opportunistic screening and stepped care interventions for older hazardous alcohol users in primary care
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools compared to parental concern for identifying speech and language delays in preschool children: a review of the diagnostic accuracy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and diagnostic tools for autism spectrum disorder in children: a review of guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal screening procedures prior to physician visits: guidelines
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Advisability of expanding the Québec newborn blood screening program]
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Portable bone mineral density scanners for screening and diagnosis of osteoporosis: uses, limitations, and guidelines
2013	Health Council of the Netherlands Gezondheidsraad (GR)	Population Screening Act: national population screening programme for bowel cancer
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary of the exploration of the scientific literature on the effects of prostate cancer screening decision aids for the expert panel of the Collège des médecins du Québec]
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening for sexually transmitted infections: a review of guidelines
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for oral cancer: a targeted evidence update for the U.S. Preventive Services Task Force
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for hypertension in children and adolescents to prevent cardiovascular disease: systematic review for the U.S. Preventive Services Task Force.
2013	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry: Maple Syrup Urine Disease, Homocystinuria, Glutaric Aciduria Type I, Isovaleric Acidaemia, Long-chain 3-Hydroxyacyl CoA Dehydrogenase Deficiency]
2013	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital screening mammography. Critical analysis of the article by Chiarelli (2013) and literature review]
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Colorectal-cancer-screening update; status in Austria and European countries; and quality assurance of screening-colonoscopy]
2013	NIHR Health Technology Assessment programme	Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study
2013	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, safety and efficiency of computed tomographic colonography vs. colonoscopy as colorectal cancer screening test]
2013	NIHR Health Technology Assessment programme	Adjunctive colposcopy technologies for examination of the uterine cervix - DySIS, LuViva Advanced Cervical Scan and Niris Imaging System: a systematic review and economic evaluation
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Reorientation of the Austrian parent-child preventive care programme - Part IX: Evidence-based screening guidelines for pregnant women and children (0 – 6 yrs.)]
2013	HAYES, Inc.	Low-dose helical (spiral) computed tomography for lung cancer screening
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for biotinidase deficiency]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for congenital adrenal hyperplasia]
2013	Canary Health Service	[Cost-effectiveness of neonatal screening for classical galactosemia]